NOW AVAILABLE: PRAXBIND - Immediate PRADAXA Reversal

Only FDA-approved specific reversal agent for a NOAC

When reversal of the anticoagulant effects of Pradaxa® (dabigatran etexilate) is needed:

  • For emergency surgery/urgent procedures
  • In life-threatening or uncontrolled bleeding

This indication is approved under accelerated approval based on a reduction in unbound dabigatran and normalization of coagulation parameters in healthy volunteers. Continued approval for this indication may be contingent upon the results of an ongoing cohort case series study.